Navigation Links
Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:6/5/2010

ntly higher levels of expression of four genes related to proliferation in African-American patients (p<0.05).

Additionally, Genomic Health, in partnership with investigators from several academic institutions, will present a separate study, "Recurrence risk of node-negative and ER-positive early stage breast cancer patients by combining Recurrence Score, pathologic, and clinical information: A meta analysis approach" (Abstract #509), demonstrating that combining the Oncotype DX Recurrence Score with pathology and clinical measures (RSPC) supplements the assessment of baseline recurrence risk.  The Oncotype DX Recurrence Score (RS), and the individual biology it identifies, remains the recommended method for predicting relative chemotherapy benefit for early-stage breast cancer.

Physicians currently integrate the RS result with other pathology and clinical (PC) measures through their own individual processes and have not had a formal way of integrating this information when assessing recurrence risk.  Using this meta-analysis approach, Genomic Health and its clinical collaborators have employed statistical methods to leverage the larger experience of over 1,700 breast cancer patients from two randomized trials, and integrate the RS with PC measures in order to provide greater clarity, especially when  PC measures and the RS are discordant.

The RSPC prediction of recurrence risk, which is driven in large part by the RS, reflects the individualized assessment of the continuous biology of breast cancer.  For the majority of patients, the prediction of recurrence risk by RSPC and RS are similar.  As expected, changes in risk category occurred more frequently for scores near the category boundaries and were most likely for patients with intermediate Recurrence Scores.  The integration of all these measures reduced the number of p
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
2. Mount Sinai Medical Center Drives Genomic Research Collaboration with Isilon Scale-out NAS
3. Synthetic Genomics Inc. Applauds the Venter Institutes Work in Creating the First Synthetic Bacterial Cell
4. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
5. Trinean Reduces Volume and Time Requirements for Genomic DNA Quantification
6. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
7. Genedata Announces Five-Year Agreement Extension with Kluyver Centre for Genomics of Industrial Fermentation
8. The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB)
9. Institute for Systems Biology uses Complete Genomics genome sequencing service to verify gene responsible for Miller syndrome
10. Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
11. Melanoma transcriptome reveals novel genomic alterations not seen before
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... DALLAS , September 29, 2014 /PRNewswire/ ... market research report "Epigenetics Market by Product (Modifying ... Consumables, Kit, Bisulphite Conversion Kit, Reagents), by ... User - Global Forecast to 2019", published ... the major drivers, restraints, opportunities, current market ...
(Date:9/29/2014)... 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: ... proprietary technologies and products for advanced microarray diagnostics, is ... to Chairman of the Board of Directors of ... continue to serve as a Director on the Board ... "We are very pleased to have ...
(Date:9/29/2014)... , Sept. 29, 2014  Perrigo Company plc ... that it has transferred a portfolio of preclinical ... 2013 acquisition of Elan Corporation plc, to drug ... of the agreement, Perrigo will receive an upfront ... and royalties on any future sales derived from ...
(Date:9/28/2014)... Boston, Mass. (PRWEB) September 29, 2014 ... delivers integrated cold chain management solutions for highly ... Brian Brazill, will present the company’s Advantage Transport ... Chain GDP & Temperature Management Logistics Global Forum ... will explain and demonstrate the company’s lab software ...
Breaking Biology Technology:Epigenetics Market Worth $783.17 Million by 2019 2Epigenetics Market Worth $783.17 Million by 2019 3Epigenetics Market Worth $783.17 Million by 2019 4SQI Diagnostics Announces New Chairman of Board of Directors 2Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 2Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 3Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 4Consulting Engineer Brian Brazill to Demonstrate Modality Solutions Advantage Transport Simulation Laboratory Software at 12th Annual Cold Chain Global Forum 2Consulting Engineer Brian Brazill to Demonstrate Modality Solutions Advantage Transport Simulation Laboratory Software at 12th Annual Cold Chain Global Forum 3
... PARSIPPANY, N.J., Sept. 1, 2011 New data, published ... the long-term safety and tolerability of FIRMAGON ® ... cancer when used over three years.(1) The new study ... III study (CS21) in which FIRMAGON ® was ...
... BRUSSELS, September 1, 2011 The current ... successful research into blood-related diseases must ensure the safety ... This was a key message of a ... by the European Parliament and attended by doctors, researchers, ...
... September 1, 2011 The medical imaging ... has secured an order for their magnetic resonance imaging ... The software will be used in clinical practice to ... The software, SyMRI Diagnostics, includes tools to automatically ...
Cached Biology Technology:New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 2New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 3New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 4New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 5New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology 6Crucial Directives Must be Revised to Protect Patients' Interests and Improve Access to Treatment 2Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation 2Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation 3
(Date:9/29/2014)... President Juan Manuel Santos has presented Dr. Cristin ... Society, with the prestigious Order of San Carlos. ... citizens, foreign civilians and military officers who have ... the field of international relations. , An international ... Samper was invited to the Colombian Residence in ...
(Date:9/29/2014)... deemed inaccessible or esoteric. Yet in the modern world, ... daily lives and a decisive role in the discovery ... scenes. , UC Santa Barbara,s Paul Atzberger, a professor ... of mechanical engineering, often works in areas where science ... in the Proceedings of the National Academy of ...
(Date:9/29/2014)... a real-time feedback system together with a human energy ... reduction of 37% in energy consumption when compared to ... equivalent to a reduction of 713.71 kg of CO ... another eight halls, exposed only to the real-time feedback ... 3.5% reduction in energy consumption. , Student,s energy-use behaviour ...
Breaking Biology News(10 mins):At the interface of math and science 2At the interface of math and science 3At the interface of math and science 4
... for the planet,s gravest health threats is hatched by ... new report sets out a 10-point plan for this ... flu. Ministers of health and agriculture will formulate ... the threat of avian flu and other emerging infectious ...
... Integrates with,Citrix Password Manager Single-Sign On Solution ... Oct. 22 Fujitsu Computer Products of,America, ... products including,hard disk drives, peripherals and biometric ... has been verified as Citrix,Ready(TM). The PalmSecure ...
... The leading cause of death in all cancer patients ... a form of treatment in which chemicals are used to ... biochemists that focuses on cancer cells reports that ingesting apigenin ... fruit improves cancer cells, response to chemotherapy. ...
Cached Biology News:Avian flu threat: New approach needed 2Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 2Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 3Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 4How eating fruit and vegetables can improve cancer patients' response to chemotherapy 2
Hamster Serum; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels....
... Kit with CyScribe GFX Purification Kit, ... purification of Cy3- and Cy5-labeled cDNA.Optimized ... cDNA labeling and purification.Flexible and optimized ... labeling reactions with either Cy3- or ...
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
Homo sapiens toll interacting protein Antigen: Recombinant Protein...
Biology Products: